Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard FitzGerald

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
BMC Pulmonary Medicine|May 7, 2017
Single use and conventional bronchoscopes for Broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591)Seher Raza Zaidi, Andrea M Collins, Elena Mitsi, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|November 14, 2003
Environment affects stress in exercised turbotErich H Van Ham, Rogier D Van Anholt, Guus Kruitwagen, et al.
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.
Journal of Inherited Metabolic Disease|February 22, 2020
Nitisinone causes acquired tyrosinosis in alkaptonuriaMilad Khedr, Maggie S Cooper, Andrew T Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.
Clinical Pharmacology in Drug Development|June 26, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate MacrofilaricideGraham Devereux, Marcin Bula, Karen Tripp, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial PneumoniaShampa Das, Richard Fitzgerald, Asad Ullah, et al.
Wellcome Open Research|April 4, 2022
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)Michael Abouyannis, Richard FitzGerald, Mwanajuma Ngama, et al.
Ebiomedicine|February 28, 2025
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adultsMichael Abouyannis, Yvonne K Nyambura, Samson Ngome, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infectionSaye H Khoo, Richard FitzGerald, Christopher J Edwards, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
BMC Pulmonary Medicine|May 7, 2017
Single use and conventional bronchoscopes for Broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591)Seher Raza Zaidi, Andrea M Collins, Elena Mitsi, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|November 14, 2003
Environment affects stress in exercised turbotErich H Van Ham, Rogier D Van Anholt, Guus Kruitwagen, et al.
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.
Journal of Inherited Metabolic Disease|February 22, 2020
Nitisinone causes acquired tyrosinosis in alkaptonuriaMilad Khedr, Maggie S Cooper, Andrew T Hughes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2022
Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionRichard FitzGerald, Laura Dickinson, Laura Else, et al.
Clinical Pharmacology in Drug Development|June 26, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate MacrofilaricideGraham Devereux, Marcin Bula, Karen Tripp, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial PneumoniaShampa Das, Richard Fitzgerald, Asad Ullah, et al.
Wellcome Open Research|April 4, 2022
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)Michael Abouyannis, Richard FitzGerald, Mwanajuma Ngama, et al.
Ebiomedicine|February 28, 2025
Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adultsMichael Abouyannis, Yvonne K Nyambura, Samson Ngome, et al.
The Journal of Antimicrobial Chemotherapy|June 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infectionSaye H Khoo, Richard FitzGerald, Christopher J Edwards, et al.
Pageof 6